| Literature DB >> 33520589 |
Samina Shabbir1, Muhammad Fakhar-E-Alam Kulyar2, Zeeshan Ahmad Bhutta3, Prerona Boruah4, Muhammad Asif5.
Abstract
Titanium dioxide nanoparticles (TiO2 NPs) are the most produced nanomaterial for food additives, pigments, photocatalysis, and personal care products. These nanomaterials are at the forefront of rapidly developing indispensable nanotechnology. In all these nanomaterials, titanium dioxide (TiO2) is the most common nanomaterial which is being synthesized for many years. These nanoparticles of TiO2 are widely used at the commercial level, especially in cosmetic industries. High usage in such a way has increased the toxicological consequences of the human population. Several studies have shown that TiO2 NPs accumulated after oral exposure or inhalation in the alimentary canal, lungs, heart, liver, spleen, cardiac muscle, and kidneys. Additionally, in mice and rats, they disturb glucose and lipid homeostasis. Moreover, TiO2 nanoparticles primarily cause adverse reactions by inducing oxidative stress that leads to cell damage, inflammation, genotoxicity, and adverse immune responses. The form and level of destruction are strongly based on the physical and chemical properties of TiO2 nanoparticles, which administer their reactivity and bioavailability. Studies give indications that TiO2 NPs cause both DNA strand breaks and chromosomal damages. The effects of genotoxicity do not depend only on particle surface changes, size, and exposure route, but also relies on the duration of exposure. Most of these effects may be because of a very high dose of TiO2 NPs. Despite increased production and use, epidemiological data for TiO2 NPs is still missing. This review discusses previous research regarding the impact of TiO2 NP toxicity on human health and highlights areas that require further understanding in concern of jeopardy to the human population. This review is important to point out areas where extensive research is needed; thus, their possible impact on individual health should be investigated in more details.Entities:
Keywords: Jeopardy; Nanomaterials; Nanoparticles; Nanotechnology; TiO2; Titanium dioxide nanoparticles
Year: 2021 PMID: 33520589 PMCID: PMC7835448 DOI: 10.1007/s12668-021-00836-3
Source DB: PubMed Journal: Bionanoscience ISSN: 2191-1630
Fig. 1Possibility of release, absorption, and impact of TiO2 NPs in an ecosystem (1) inhalation; (2) ingestion; and (3) deposition [19]
Fig. 2Schematic diagram of the toxicity ofTiO2 NPs [25]
In vivo studies conducted to evaluate the toxic properties of TiO2 NPs
| Crystal phase composition (particle size in nm) | Type of exposure | Body system under evaluation | Type and number of animals | Results | Reference |
|---|---|---|---|---|---|
| Anatase TiO2 (15) | Oropharyngeal aspiration: ∼0.8 mg/kg TiO2 | Respiratory system | 5–6 male BALB/c mice | Increased airway reactivity by TiO2 in toluene diisocyanate sensitized mice. TiO2 increased neutrophils and alveolar macrophages in bronchoalveolar lavage of toluene diisocyanate sensitized mice. | [ |
| Anatase + Brookite TiO2 (20) | Inhalation: 8–30 mg/m3 for 0.5 h (acute exposure); 30 mg/m3 for 1 h a day, 4 days a week for 4 weeks (sub-chronic exposure) | Respiratory system | 4–6 male Crl:OF1 mice per group | Reduced expiratory flow in all the exposure situations | [ |
| TiO2 (35) | IV injection of 0.8 mg TiO2 for 2 consecutive gestational days. | Nervous system | Pregnant mice | TiO2 found in fetal brain | [ |
| Rutile TiO2 (15, 50, 100) | ID injections of 20 μg TiO2 with/without mite allergen | Dermal and mucosal system | 11 male mice per group | Atopic dermatitis, increased ear thickness, increased IL-4, IL-13, MCs, and EOSs. Decrease IFN-γ | [ |
| Rutile Fe-doped TiO2 (diameter, 7; length, 80) | 1 and 5 mg/kg TiO2 intratracheal instillation | Cardiovascular system | 4 male Wistar rats per group | Heart rate and systolic blood pressure increased | [ |
| Anatase TiO2 (5, 10, 60, 90) | IP injection 5, 10, 50, 100, 150, and 200 mg/kg once a day for 14 days | Liver | 10 ICR mice per group | Accumulation of titanium in the spleen, lung, brain, and heart; apoptosis of hepatocytes, damage to mitochondria, generation of ROS, and expression disorders of protective genes in the liver of mice | [ |
| Anatase TiO2 (5 ± 1) | Intratracheal instillation: 0.8–20 mg/kg TiO2. | Renal system | 8 male Sprague-Dawley rats per group | Blood urea nitrogen increased; Ketone bodies, choline, low-density lipoprotein, alanine, and glutamic acid increased; lactate, pyruvate, and creatine decreased. TEM analysis: tubule epithelial cell damage, vascular deformity | [ |
| Anatase TiO2 (thickness: 10–15; diameter: 45.87 ± 7.75) | Intraarticular injection of TiO2 of 0.2, 2, 20 mg/kg in knee joints every other day for 4 times | Musculoskeletal system | 10 male Sprague-Dawley rats per group | Glutathione peroxidase, oxidized glutathione, malondialdehyde, and superoxide dismutase increased. | [ |
| Anatase TiO2 (25–70) | SQ injection of 100 μL of TiO2 at 1mg/mL at 3, 7, 10 and 14 days post-coitum. | Reproductive system | 6 pregnant Slc:ICR mice per group | Decreased sperm production, number of Sertoli cells, and epididymal sperm motility; disorganized and disrupted seminiferous tubules; a little mature sperm. | [ |
Fig. 3The dynamic nature of NPs in vivo. Radiation penetrates the systemic circulation. The black line represents the nanoparticle confirmation path, and the dotted line represents the virtual path (other organs = spleen, heart, genitals) [50]
Overview of past studies on genotoxicity of TiO2 NPs
| Sr. no. | Crystalline structure | Dosage | Cause | Result | Exposure type | Reference |
|---|---|---|---|---|---|---|
| 1 | Anatase | 50, 250, and 500 mg/kg body weight of TiO2 NPs | Chromosomal aberrations in mice spinal cord bone marrow genetic disturbance | + | Intraperitoneal Injection | [ |
| 2 | Anatase | 1, 4, and 16 g/kg BW | Liver effect hepatocytes located around the centrilobular veins’ oxidative stress by 4-HNE and Kupffer cells | + | Intraperitoneal injection | [ |
| 3 | Anatase | 2.5 or 5 mg kg−1 body weight | Increased numbers of terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling-positive (apoptotic) germ and interstitial space cells, flagellar abnormalities, excess residual cytoplasm, and ROS | + | Intraperitoneal injection | [ |
| 4 | Anatase | 0.1 to 100 μg mL−1. The TiO2 NPs | Decreases cell viability in both A549 and 16HBE cells; Intracellular ROS levels increased and decreased global DNA methylation | + | Inhalation administration | [ |
| 5 | Anatase | 1.0, 5.0 mg/kg of TiO2 NPs | Alveolus of the lung | + | Intratracheal instillation | [ |
| 6 | Anatase | 5, 50, or 500 mg/kg of TiO2 NPs | Mutations in | + | Orally administered | [ |
| 7 | Anatase | 0.8, 7.2, and 28.5 mg/m3 | Genotoxic effects in C57BL/6 DNA damage | + | Intratracheal instillation | [ |
| 8 | Rutile and Anatase | 500 mg/kg b.w of TiO2 NPs | DNA fragmentation point mutation of Presenilin 1 gene at exon 5, Alzheimer’s disease | + | Orally administered | [ |
| 9 | Rutile and Anatase | 25, 75, and 125 μM of TiO2 NPs | DNA intensity in tail, Olive tail moment, and chromosomal aberrations (CA) at 75 and 125 μM but not at 25 μM | + | Short-term human peripheral blood cultures | [ |
| 10 | Anatase | 12.5, 25, 50, and 100 μg/mL of TiO2 NPs | DNA damage | + | Continuous supply to roots | [ |
| 11 | Anatase | 50 mg/kg 10 nm TiO2 NPs | DNA damage accumulated in liver and lung tissues, metabolic homeostasis in the liver and by inducing oxidative stress, inflammatory responses, and apoptosis in lung | + | Intraperitoneal injection | [ |
| 12 | Anatase | 2, 10, or 50 mg/kg TiO2 NPs | Gene mutation assay micronucleus assay | - | Intravenous injections | [ |
| 13 | Anatase | 0.08 to 1.60 mg/mL TiO2 NPs | Wing spot test DNA damage cytotoxic effects on midgut and imaginal disc tissues of larvae | + | Ingestion | [ |
| 14 | Anatase | Mutagenic effect at 1.5625 and 3.125 mM, while 78.0 nm NCs increased mutant spots no clastogenic/aneugenic effects. | - | [ | ||
| 15 | Anatase | (0, 140, 300, 645, or 1387 mg/kg of TiO2 NPs | No significant acute hematological or genetic toxicity | - | Intravenous Injection | [ |
| 16 | Anatase, rutile, anatase/rutile | 18, 54, 162, or 486 μg of TiO2 NPs | Increased collagen staining and fibrosis, inflammation neutrophil influx in BALF, pathological effects | + | Intratracheal installation | [ |
| 17 | Anatase TiO2 NPs | 0, 10, 50 and 200μg/mL | DNA double strand breaks in bone marrow cells | + | Oral administration | [ |
| 18 | Anatase | 5 mg/kg bw TiO2 NPs | DNA strand breaks Formamidopyrimidine DNA glycosylase-oxidized purines SCSA Perm DNA fragmentation | + | Intravenously administration | [ |
| 19 | Anatase | 20 μg/mL for 24, 48, 72, and 96 h | kidney proximal tubular cells (NRK-52E ROS mitosis decreased apoptotic cells increased BrdU immunoreactivity reduced | + | [ | |
| 20 | Anatase | 50 mg/kg | DNA damage mainly resulted from oxidized nucleotides, oxidative stress, apoptosis in the lung | + | Intraperitoneal injection | [ |